Skip to main content
Year archive

Zealand Pharma — 2019 filings

All 171 regulatory filings released by Zealand Pharma (ZEAL) in 2019, sourced directly from the official regulator.

171 Filings
2019 Period
2019 filings (171)
Filing Released Lang
Total number of shares and voting rights in Zealand Pharma at December 31, 2019
Share Issue/Capital Change
2019-12-31 English
Total number of shares and voting rights in Zealand Pharma at December 31, 2019
Share Issue/Capital Change
2019-12-31 English
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Director's Dealing
2019-12-13 English
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Director's Dealing
2019-12-13 English
Director's Dealing 2019
Director's Dealing
2019-12-13 English
Zealand Pharma partner Beta Bionics receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System
Regulatory Filings
2019-12-10 English
Zealand Pharma partner Beta Bionics receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System
Regulatory Filings
2019-12-10 English
Regulatory Filings 2019
Regulatory Filings
2019-12-10 English
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Director's Dealing
2019-12-05 English
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Director's Dealing
2019-12-05 English
Director's Dealing 2019
Director's Dealing
2019-12-05 English
Zealand Pharma grants new warrants under the employee warrant program
Share Issue/Capital Change
2019-12-05 English
Capital/Financing Update 2019
Capital/Financing Update
2019-12-05 English
Total number of shares and voting rights in Zealand Pharma at November 30, 2019
Share Issue/Capital Change
2019-11-29 English
Total number of shares and voting rights in Zealand Pharma at November 30, 2019
Share Issue/Capital Change
2019-11-29 English
Notification of managers and closely related parties’ transactions with Zealand Pharma shares in connection with employee warrant program
Director's Dealing
2019-11-27 English
Notification of managers and closely related parties’ transactions with Zealand Pharma shares in connection with employee warrant program
Director's Dealing
2019-11-27 English
Notification of managers and closely related parties’ transactions with Zealand Pharma shares in connection with employee warrant program
Director's Dealing
2019-11-27 English
Notification of managers and closely related parties’ transactions with Zealand Pharma shares in connection with employee warrant program
Director's Dealing
2019-11-27 English
Notification of managers and closely related parties’ transactions with Zealand Pharma shares in connection with employee warrant program
Director's Dealing
2019-11-27 English
Director's Dealing 2019
Director's Dealing
2019-11-27 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2019-11-27 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2019-11-27 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2019-11-27 English
Director's Dealing 2019
Director's Dealing
2019-11-27 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-11-22 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-11-22 English
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-11-14 English
Zealand Pharma completes Phase 3 clinical program for HypoPal® rescue pen, initiates a new Phase 2 clinical proof of concept trial with dasiglucagon, and secures DKK 560 million in additional investme
Interim / Quarterly Report 9M 2019
2019-11-14 English
Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics
M&A Activity
2019-10-22 English
Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics
M&A Activity
2019-10-22 English
M&A Activity 2019
M&A Activity
2019-10-22 English
Total number of shares and voting rights in Zealand Pharma at September 30, 2019
Share Issue/Capital Change
2019-09-30 English
Total number of shares and voting rights in Zealand Pharma at September 30, 2019
Share Issue/Capital Change
2019-09-30 English
Total number of shares and voting rights in Zealand Pharma at September 30, 2019
Share Issue/Capital Change
2019-09-30 English
Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia
Regulatory Filings
2019-09-24 English
Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia
Regulatory Filings
2019-09-24 English
Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia
Regulatory Filings
2019-09-24 English
Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia
Regulatory Filings
2019-09-24 English
Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia
Earnings Release FY 2019
2019-09-24 English
Earnings Release 2019
Earnings Release FY 2019
2019-09-24 English
Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia
Regulatory Filings
2019-09-24 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-09-13 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-09-13 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-09-13 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-09-13 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-09-13 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-09-13 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-09-13 English
Zealand Pharma completes subscription of new shares and registration of capital increase
Share Issue/Capital Change
2019-09-11 English
Zealand Pharma completes subscription of new shares and registration of capital increase
Share Issue/Capital Change
2019-09-11 English
Zealand Pharma completes subscription of new shares and registration of capital increase
Share Issue/Capital Change
2019-09-11 English
Zealand Pharma completes subscription of new shares and registration of capital increase
Share Issue/Capital Change
2019-09-11 English
Zealand Pharma completes subscription of new shares and registration of capital increase
Share Issue/Capital Change
2019-09-11 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-09-11 English
Zealand Pharma completes subscription of new shares and registration of capital increase
Share Issue/Capital Change
2019-09-11 English
Update regarding registration of new shares for Zealand Pharma
Share Issue/Capital Change
2019-09-10 English
Update regarding registration of new shares for Zealand Pharma
Share Issue/Capital Change
2019-09-10 English
Update regarding registration of new shares for Zealand Pharma
Share Issue/Capital Change
2019-09-10 English
Update regarding registration of new shares for Zealand Pharma
Share Issue/Capital Change
2019-09-10 English
Update regarding registration of new shares for Zealand Pharma
Share Issue/Capital Change
2019-09-10 English
Update regarding registration of new shares for Zealand Pharma
Share Issue/Capital Change
2019-09-10 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-09-10 English
Zealand Pharma major shareholder announcement: Van Herk Investments
Major Shareholding Notification
2019-09-06 English
Zealand Pharma major shareholder announcement: Van Herk Investments
Major Shareholding Notification
2019-09-06 English
Zealand Pharma major shareholder announcement: Van Herk Investments
Major Shareholding Notification
2019-09-06 English
Zealand Pharma major shareholder announcement: Van Herk Investments
Major Shareholding Notification
2019-09-06 English
Zealand Pharma major shareholder announcement: Van Herk Investments
Major Shareholding Notification
2019-09-05 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-09-05 English
Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
Share Issue/Capital Change
2019-09-05 English
Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
Share Issue/Capital Change
2019-09-05 English
Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
Share Issue/Capital Change
2019-09-05 English
Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
Share Issue/Capital Change
2019-09-05 English
Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
Capital/Financing Update
2019-09-05 English
Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million
Share Issue/Capital Change
2019-09-05 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-09-05 English
Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
Regulatory Filings
2019-09-03 English
Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
Regulatory Filings
2019-09-03 English
Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
Regulatory Filings
2019-09-03 English
Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
Regulatory Filings
2019-09-03 English
Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
Regulatory Filings
2019-09-03 English
Regulatory Filings 2019
Regulatory Filings
2019-09-03 English
Total number of shares and voting rights in Zealand Pharma at August 31, 2019
Share Issue/Capital Change
2019-08-30 English
Total number of shares and voting rights in Zealand Pharma at August 31, 2019
Share Issue/Capital Change
2019-08-30 English
Total number of shares and voting rights in Zealand Pharma at August 31, 2019
Share Issue/Capital Change
2019-08-30 English
Total number of shares and voting rights in Zealand Pharma at August 31, 2019
Share Issue/Capital Change
2019-08-30 English
Total number of shares and voting rights in Zealand Pharma at August 31, 2019
Share Issue/Capital Change
2019-08-30 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-08-30 English
Board/Management Information 2019
Board/Management Information
2019-08-28 English
Correction: Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Board/Management Information
2019-08-28 English
Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Board/Management Information
2019-08-28 English
Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Board/Management Information
2019-08-28 English
Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Board/Management Information
2019-08-28 English
Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Board/Management Information
2019-08-28 English
Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
Board/Management Information
2019-08-28 English
Board/Management Information 2019
Board/Management Information
2019-08-28 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-08-23 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-08-23 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-08-23 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-08-23 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-08-23 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-08-23 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-08-23 English
Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S.
Earnings Release H1 2019
2019-08-15 English
Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S.
Earnings Release H1 2019
2019-08-15 English
Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S.
Earnings Release H1 2019
2019-08-15 English
Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S.
Earnings Release H1 2019
2019-08-15 English
Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S.
Earnings Release H1 2019
2019-08-15 English
Earnings Release 2019
Earnings Release H1 2019
2019-08-15 English
Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S.
Interim / Quarterly Report H1 2019
2019-08-15 English
Zealand Pharma announces change in corporate management
Board/Management Information
2019-07-29 English
Board/Management Information 2019
Board/Management Information
2019-07-29 English
Total number of shares and voting rights in Zealand Pharma at June 30, 2019
Share Issue/Capital Change
2019-06-28 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-06-28 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-06-14 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-06-14 English
Director's Dealing 2019
Director's Dealing
2019-06-14 English
Director's Dealing 2019
Director's Dealing
2019-06-14 English
Director's Dealing 2019
Director's Dealing
2019-06-14 English
Director's Dealing 2019
Director's Dealing
2019-06-14 English
Director's Dealing 2019
Director's Dealing
2019-06-14 English
Zealand Pharma announces amendments to its Articles of Association following the granting of warrants
Share Issue/Capital Change
2019-06-13 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-06-13 English
Zealand Pharma implements a new long-term incentive program and grants new warrants under the employee warrant program
Remuneration Information
2019-06-13 English
Remuneration Information 2019
Remuneration Information
2019-06-13 English
Director's Dealing 2019
Director's Dealing
2019-06-12 English
Director's Dealing 2019
Director's Dealing
2019-06-10 English
Director's Dealing 2019
Director's Dealing
2019-06-06 English
Beta Bionics and Zealand Pharma announce superior glycemic control in Phase 2 home-use clinical trial testing the iLet™ bionic pancreas using dasiglucagion
Regulatory Filings
2019-06-06 English
Regulatory Filings 2019
Regulatory Filings
2019-06-06 English
Total number of shares and voting rights in Zealand Pharma as of May 31, 2019
Share Issue/Capital Change
2019-06-03 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-06-03 English
Correction: Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-05-28 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-05-28 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-05-28 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-05-28 English
Zealand Pharma initiates several Phase 3 studies and grows cash position in the first quarter of 2019
Earnings Release Q1 2019
2019-05-16 English
Earnings Release 2019
Earnings Release Q1 2019
2019-05-16 English
Zealand Pharma achieves primary and all key secondary endpoints in confirmatory Phase 3 trial with dasiglucagon for severe hypoglycemia
Regulatory Filings
2019-05-14 English
Legal Proceedings Report 2019
Legal Proceedings Report
2019-05-14 English
Zealand Pharma announces amendments to its Articles of Association following the granting of warrants
Share Issue/Capital Change
2019-04-17 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-04-17 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2019-04-10 English
Director's Dealing 2019
Director's Dealing
2019-04-10 English
Zealand Pharma grants new warrants under employee warrant program
Share Issue/Capital Change
2019-04-10 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-04-10 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-04-05 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-04-05 English
Zealand Pharma announces Emmanuel Dulac as new CEO
Board/Management Information
2019-04-05 English
Board/Management Information 2019
Board/Management Information
2019-04-05 English
Zealand Pharma’s Annual General Meeting in 2019
AGM Information
2019-04-04 English
AGM Information 2019
AGM Information
2019-04-04 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-03-29 English
Total number of shares and voting rights in Zealand Pharma at March 31, 2019
Share Issue/Capital Change
2019-03-29 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-03-21 English
Zealand Pharma announces completion of the share subscription by Alexion Pharmaceuticals, Inc. and registration of capital increase
Governance Information
2019-03-21 English
Zealand Pharma announces completion of the share subscription by Alexion Pharmaceuticals, Inc. and registration of capital increase
Share Issue/Capital Change
2019-03-21 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-03-20 English
Zealand Pharma increases its share capital as a consequence of a new issue of shares
Share Issue/Capital Change
2019-03-20 English
M&A Activity 2019
M&A Activity
2019-03-20 English
Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases
Regulatory Filings
2019-03-20 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-03-15 English
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2019-03-15 English
AGM Information 2019
AGM Information
2019-03-12 English
Zealand Pharma convenes its Annual General Meeting 2019
Proxy Solicitation & Information Statement
2019-03-12 English
Annual Report 2018
Annual Report FY 2018
2019-03-07 English
Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress
Earnings Release FY 2018
2019-03-07 English
Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress
Earnings Release FY 2018
2019-03-07 English
Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress
Earnings Release FY 2018
2019-03-07 English
Board/Management Information 2019
Board/Management Information
2019-01-23 English
Changes to Zealand Pharma’s Executive Management
Board/Management Information
2019-01-23 English